Adrian was just nine months old when he had his first life-threatening allergic reaction.  

After suffering anaphylaxis to wheat, further testing revealed he had multiple food allergies, including peanut allergy. Since then, everyday life has required careful planning and constant vigilance - from grocery shopping and birthday parties to family holidays and eating out. 
 

“Because of his allergies, we’re always thinking about what Adrian can and can’t eat, and his food choices are often limited,” Adrian’s mum, Yolanda, said. “It can be isolating at times, particularly when so many social activities and childhood experiences involve food.” 

Peanut allergy is one of the most common food allergies affecting children. It occurs when the immune system mistakenly identifies peanut protein as harmful and triggers an allergic reaction. For children like Adrian, even tiny amounts of exposure can cause severe anaphylaxis.  

“The rate of peanut allergy has increased over recent decades, and, unlike many other common food allergies, it is not commonly outgrown,” Dr Lara Ford, Staff Specialist, Allergy and Immunology, said. “It is a condition that is often life-long and can be life-threatening.”

Managing peanut allergy currently relies on strict allergen avoidance and being prepared to recognise and respond to allergic reactions when they occur.  

 

“Living with peanut allergy extends beyond the physical risk of an allergic reaction and can affect a child and family’s social, emotional and psychological wellbeing,” Dr Ford said.  

For Adrian’s family, the ongoing risk of accidental exposure and cross-contamination led them to take part in a clinical trial designed to desensitise children with peanut allergy.  

“As a parent of a child with anaphylaxis, I worry about Adrian’s future,” Yolanda said. “We want to minimise the impact of accidental exposure as a result of cross-contamination as much as possible.”

The clinical trial at The Children’s Hospital at Westmead contributes to research exploring new approaches to peanut allergy treatment. It is investigating if the treatment can help reduce the severity of allergic reactions, helping children live with fewer restrictions and less anxiety.  

Clinical trials play an important role in advancing allergy research and improving treatment options for future generations. Families like Adrian’s are helping researchers better understand how new treatments could improve the lives of children living with peanut allergy.  

“We are very grateful to families who give up their time and effort to participate in a trial that may have no direct benefit to them,” Dr Ford said. “Access to trials like this gives families optimism that their child’s life can be less restricted by their health condition.”

Participation in the study is a significant commitment. For Adrian and his family, it means travelling from Canberra for regular hospital appointments, blood and skin testing, supervised food challenges, as well as ongoing daily treatment requirements at home. 

“Adrian has been very positive about the trial,” Yolanda said. “He has been incredibly brave.”

For Adrian and his family, taking part in the trial has been an opportunity to contribute to allergy research while helping Adrian build confidence as he lives with his allergies.  

“Being part of the trial gives us a positive outlook for Adrian’s future and the chance to help other families facing the same challenges,” Yolanda said.  

Looking ahead, Yolanda hopes Adrian’s allergies will have less influence on the experiences and opportunities available to him.

“We want Adrian to enjoy the activities he loves with more freedom. We don’t want his allergies to set the limits for him.”